|

Arthritis Clinical Trials in Kansas City, MO

13 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable CancerPhase 1<1 mi
Nipocalimab in Moderate to Severe Sjogren's DiseasePhase 3<1 mi
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseasePhase 4<1 mi
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)Phase 2<1 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)Phase 3<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPhase 3<1 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneePhase 3<1 mi
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's SyndromePhase 33 mi
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease—3 mi
Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II DiabetesPhase 43 mi
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 310 mi
MAD Study of IA-14069Phase 113 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.